Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) as prognostic markers in locally advanced squamous cell oropharyngeal cancer: a retrospective, observational, multicenter experience

Martucci Francesco; Martucci F.; Cima S.; Antognoni P.; Richetti A.

首页> 外文期刊>Strahlentherapie und Onkologie >Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) as prognostic markers in locally advanced squamous cell oropharyngeal cancer: a retrospective, observational, multicenter experience

【24h】

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) as prognostic markers in locally advanced squamous cell oropharyngeal cancer: a retrospective, observational, multicenter experience

机译：中性粒细胞与淋巴细胞比率（NLR）和血小板到淋巴细胞比（PLR）作为局部晚期鳞状细胞口咽癌的预后标志物：回顾性，观察，多中心经验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Strahlentherapie und Onkologie》 |2019年第12期|共1页
作者
Martucci Francesco; Martucci F.; Cima S.; Antognoni P.; Richetti A.;
展开▼
作者单位

Oncol Inst Southern Switzerland Radiat Oncol Bellinzona Lugano Switzerland;

Oncol Inst Southern Switzerland Radiat Oncol Bellinzona Lugano Switzerland;

Univ Hosp Varese Radiat Oncol Varese Italy;

Oncol Inst Southern Switzerland Radiat Oncol Bellinzona Lugano Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) as prognostic markers in locally advanced squamous cell oropharyngeal cancer: a retrospective, observational, multicenter experience [J] . Martucci Francesco, Martucci F., Cima S., Strahlentherapie und Onkologie . 2019,第12期

机译：中性粒细胞与淋巴细胞比率（NLR）和血小板到淋巴细胞比（PLR）作为局部晚期鳞状细胞口咽癌的预后标志物：回顾性，观察，多中心经验
2. Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT) [J] . Hyder J., Jang H., Kim S., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：中性粒细胞对淋巴细胞比（NLR），血小板对淋巴细胞比（PLR）和淋巴细胞对单核细胞比（LMR）的预后值宫颈癌患者进行了明确的化学疗法（DCRT）
3. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy [J] . Ji W. H., Jiang Y. H., Ji Y. L., Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus . 2016,第5期

机译：化疗前中性粒细胞：淋巴细胞比率优于血小板：淋巴细胞比率，作为新辅助化疗治疗的局部晚期食管鳞状细胞癌的预后指标
4. Adenosine and breast cancer: Effects on tumor cell growth and lymphocyte infiltration in a three-dimensional model of tumor tissue. [D] . Bennett, Amy Kathleen. 2000

机译：腺苷和乳腺癌：在肿瘤组织的三维模型中对肿瘤细胞生长和淋巴细胞浸润的影响。
5. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR) lymphocyte to monocyte ratio (LMR) platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI) [O] . Hiren Mandaliya, Mark Jones, Christopher Oldmeadow, 2019

机译：IV期非小细胞肺癌（NSCLC）的预后生物标志物：中性粒细胞与淋巴细胞之比（NLR）淋巴细胞与单核细胞之比（LMR）血小板与淋巴细胞之比（PLR）和晚期肺癌炎症指数（ALI）
6. 176P Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) [O] . M. Vitorino, T. Tomas, S. Almeida, 2021

机译：176p中性粒细胞到淋巴细胞比（NLR）和血小板到淋巴细胞比（PLR）作为非小细胞肺癌患者的预后标志物（NSCLC）

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) as prognostic markers in locally advanced squamous cell oropharyngeal cancer: a retrospective, observational, multicenter experience

著录项

相似文献

相关主题

期刊订阅